
SynLaia Innovations provides a platform that reveals how mechanical states influence biology, aiding drug discovery. It combines spatial cell and tissue mechanomics with multi-modal omics data. The core technology supports profiling mechanical states in health and disease for research and pharma customers. It operates as a B2B biotech platform focusing on mechanomics and omics integration. As the market for mechanobiology grows, it aims to scale research workflows for labs and drug developers.

SynLaia Innovations provides a platform that reveals how mechanical states influence biology, aiding drug discovery. It combines spatial cell and tissue mechanomics with multi-modal omics data. The core technology supports profiling mechanical states in health and disease for research and pharma customers. It operates as a B2B biotech platform focusing on mechanomics and omics integration. As the market for mechanobiology grows, it aims to scale research workflows for labs and drug developers.